230 related articles for article (PubMed ID: 10498588)
21. High resolution HLA class I and II typing and CTLp frequency in unrelated donor transplantation: a single-institution retrospective study of 69 BMTs.
El Kassar N; Legouvello S; Joseph CM; Salesses P; Rieux C; Cordonnier C; Vernant JP; Farcet JP; Bierling P; Kuentz M
Bone Marrow Transplant; 2001 Jan; 27(1):35-43. PubMed ID: 11244436
[TBL] [Abstract][Full Text] [Related]
22. Feasibility and results of bone marrow transplantation from an HLA-mismatched unrelated donor for children and young adults with acquired severe aplastic anemia.
Yagasaki H; Takahashi Y; Kudo K; Ohashi H; Hama A; Yamamoto T; Tanaka M; Yoshida N; Hidaka H; Nishio N; Kojima S
Int J Hematol; 2007 Jun; 85(5):437-42. PubMed ID: 17562622
[TBL] [Abstract][Full Text] [Related]
23. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the mixed lymphocyte culture (MLC) assay as a method for selecting unrelated donors for marrow transplantation.
Mickelson EM; Longton G; Anasetti C; Petersdorf E; Martin P; Guthrie LA; Hansen JA
Tissue Antigens; 1996 Jan; 47(1):27-36. PubMed ID: 8929710
[TBL] [Abstract][Full Text] [Related]
25. The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation.
Petersdorf EW; Longton GM; Anasetti C; Martin PJ; Mickelson EM; Smith AG; Hansen JA
Blood; 1995 Aug; 86(4):1606-13. PubMed ID: 7632970
[TBL] [Abstract][Full Text] [Related]
26. CD31 mismatching affects marrow transplantation outcome.
Grumet FC; Hiraki DD; Brown BWM ; Zehnder JL; Zacks ES; Draksharapu A; Parnes J; Negrin RS
Biol Blood Marrow Transplant; 2001; 7(9):503-12. PubMed ID: 11669217
[TBL] [Abstract][Full Text] [Related]
27. Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1.
Przepiorka D; Saliba R; Cleary K; Fischer H; Tonai R; Fritsche H; Khouri IF; Folloder J; Ueno NT; Mehra R; Ippoliti C; Giralt S; Gajewski J; Donato M; Claxton D; Braunschweig I; van Besien K; Anderlini P; Andersson BS; Champlin R
Biol Blood Marrow Transplant; 2000; 6(2A):190-7. PubMed ID: 10816027
[TBL] [Abstract][Full Text] [Related]
28. Acceptable HLA-mismatching in unrelated donor bone marrow transplantation for patients with acquired severe aplastic anemia.
Yagasaki H; Kojima S; Yabe H; Kato K; Kigasawa H; Sakamaki H; Tsuchida M; Kato S; Kawase T; Morishima Y; Kodera Y;
Blood; 2011 Sep; 118(11):3186-90. PubMed ID: 21757619
[TBL] [Abstract][Full Text] [Related]
29. Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia.
Drobyski WR; Ash RC; Casper JT; McAuliffe T; Horowitz MM; Lawton C; Keever C; Baxter-Lowe LA; Camitta B; Garbrecht F
Blood; 1994 Apr; 83(7):1980-7. PubMed ID: 8142664
[TBL] [Abstract][Full Text] [Related]
30. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens.
Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Ball E; Cook D; Andresen S; Kuczkowski E; Bolwell B
Bone Marrow Transplant; 2005 Feb; 35(3):247-52. PubMed ID: 15580282
[TBL] [Abstract][Full Text] [Related]
31. Matched and mismatched allogeneic stem-cell transplantation from unrelated donors using combined graft-versus-host disease prophylaxis including rabbit anti-T lymphocyte globulin.
Finke J; Schmoor C; Lang H; Potthoff K; Bertz H
J Clin Oncol; 2003 Feb; 21(3):506-13. PubMed ID: 12560442
[TBL] [Abstract][Full Text] [Related]
32. An immunoablative regimen of fludarabine and cyclophosphamide prevents fully MHC-mismatched murine marrow graft rejection independent of GVHD.
Petrus MJ; Williams JF; Eckhaus MA; Gress RE; Fowler DH
Biol Blood Marrow Transplant; 2000; 6(2A):182-9. PubMed ID: 10816026
[TBL] [Abstract][Full Text] [Related]
33. The use of counterflow centrifugal elutriation for the depletion of T cells from unrelated donor bone marrow.
Neudorf SM; Rybka W; Ball E; Blatt J; Bloom E; Corey S; deMagalhaes-Silverman M; Koehler M; Lister J; Mierski J; Mirro J; Pincus S; Wilson J; Wollman M; Donnenberg AD
J Hematother; 1997 Aug; 6(4):351-9. PubMed ID: 9377073
[TBL] [Abstract][Full Text] [Related]
34. Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial.
Walker I; Panzarella T; Couban S; Couture F; Devins G; Elemary M; Gallagher G; Kerr H; Kuruvilla J; Lee SJ; Moore J; Nevill T; Popradi G; Roy J; Schultz KR; Szwajcer D; Toze C; Foley R;
Lancet Haematol; 2020 Feb; 7(2):e100-e111. PubMed ID: 31958417
[TBL] [Abstract][Full Text] [Related]
35. Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation.
Deeg HJ; Amylon ID; Harris RE; Collins R; Beatty PG; Feig S; Ramsay N; Territo M; Khan SP; Pamphilon D; Leis JF; Burdach S; Anasetti C; Hackman R; Storer B; Mueller B
Biol Blood Marrow Transplant; 2001; 7(4):208-15. PubMed ID: 11349807
[TBL] [Abstract][Full Text] [Related]
36. Biological significance of HLA locus matching in unrelated donor bone marrow transplantation.
Morishima Y; Kashiwase K; Matsuo K; Azuma F; Morishima S; Onizuka M; Yabe T; Murata M; Doki N; Eto T; Mori T; Miyamura K; Sao H; Ichinohe T; Saji H; Kato S; Atsuta Y; Kawa K; Kodera Y; Sasazuki T;
Blood; 2015 Feb; 125(7):1189-97. PubMed ID: 25519752
[TBL] [Abstract][Full Text] [Related]
37. HLA-C disparity between patients and unrelated donors matched for HLA-A, -B, and -DRB1 alleles: impact of serological vs. DNA typing for HLA-A and -B loci.
Prasad VK; Kernan NA; Heller G; O'Reilly RJ; Yang SY
Biol Blood Marrow Transplant; 1999; 5(2):77-85. PubMed ID: 10371359
[TBL] [Abstract][Full Text] [Related]
38. Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program.
Kojima S; Matsuyama T; Kato S; Kigasawa H; Kobayashi R; Kikuta A; Sakamaki H; Ikuta K; Tsuchida M; Hoshi Y; Morishima Y; Kodera Y
Blood; 2002 Aug; 100(3):799-803. PubMed ID: 12130489
[TBL] [Abstract][Full Text] [Related]
39. Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors.
Davies SM; DeFor TE; McGlave PB; Miller JS; Verfaillie CM; Wagner JE; Weisdorf DJ
Am J Med; 2001 Apr; 110(5):339-46. PubMed ID: 11286947
[TBL] [Abstract][Full Text] [Related]
40. High-risk HLA alleles for severe acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation.
Morishima S; Kashiwase K; Matsuo K; Azuma F; Yabe T; Sato-Otsubo A; Ogawa S; Shiina T; Satake M; Saji H; Kato S; Kodera Y; Sasazuki T; Morishima Y;
Haematologica; 2016 Apr; 101(4):491-8. PubMed ID: 26768690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
